Luminopia Licenses Pediatric Amblyopia Treatment to ROHTO
02 Jun 2026 //
PR NEWSWIRE
AVI Urges Rohto Pharmaceutical to Refocus and Engage Shareholders
07 May 2026 //
BUSINESSWIRE
UK Fund AVI Wants Chairman Of Japan Drugmaker Rohto To Leave
30 Apr 2026 //
BLOOMBERG
Asset Value Investors Urges Rohto Pharma to Focus on Core Business
08 Apr 2025 //
BUSINESSWIRE
EMA Aesthetics Announces a Long-Term Strategic and Equity Partnership with ROHTO
01 Feb 2024 //
PR NEWSWIRE
Bloomage Bio established a joint venture with Rohto Pharma and BMS
23 Jun 2022 //
PRESS RELEASE

Market Place
Sourcing Support